105 related articles for article (PubMed ID: 7151260)
1. Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse.
Moon RC; McCormick DL; Becci PJ; Shealy YF; Frickel F; Paust J; Sporn MB
Carcinogenesis; 1982; 3(12):1469-72. PubMed ID: 7151260
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice.
Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880
[TBL] [Abstract][Full Text] [Related]
3. Synthetic retinamides: effect on urinary bladder carcinogenesis by FANFT in Fischer rats.
Croft WA; Croft MA; Paulus KP; Williams JH; Wang CY; Lower GM
Carcinogenesis; 1981; 2(6):515-7. PubMed ID: 7273332
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2).
McCormick DL; Becci PJ; Moon RC
Carcinogenesis; 1982; 3(12):1473-6. PubMed ID: 6217919
[TBL] [Abstract][Full Text] [Related]
5. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
7. 13-cis-retinoic acid: effect on urinary bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in Fischer rats.
Croft WA; Croft MA; Paulus KP; Williams JH; Wang CY; Lower GM
Cancer Lett; 1981 May; 12(4):355-60. PubMed ID: 6946855
[TBL] [Abstract][Full Text] [Related]
8. Histopathological evaluation of the inhibition of rat bladder carcinogenesis by 13-cis-retinoic acid.
Squire RA; Sporn MB; Brown CC; Smith JM; Wenk ML; Springer S
Cancer Res; 1977 Aug; 37(8 Pt 2):2930-6. PubMed ID: 872122
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of murine hepatocarcinogenesis by all-trans-retinoic acid and two synthetic retinamides.
McCormick DL; Hollister JL; Bagg BJ; Long RE
Carcinogenesis; 1990 Sep; 11(9):1605-9. PubMed ID: 2144795
[TBL] [Abstract][Full Text] [Related]
10. Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide.
Sani BP; Meeks RG
Toxicol Appl Pharmacol; 1983 Sep; 70(2):228-35. PubMed ID: 6226123
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
[TBL] [Abstract][Full Text] [Related]
12. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of 4,4'-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl) nitros-amine.
Fukushima S; Hirose M; Hagiwara A; Hasegawa R; Ito N
Carcinogenesis; 1981; 2(10):1033-7. PubMed ID: 7296757
[TBL] [Abstract][Full Text] [Related]
14. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat.
Becci PJ; Thompson HJ; Grubbs CJ; Brown CC; Moon RC
Cancer Res; 1979 Aug; 39(8):3141-4. PubMed ID: 455298
[TBL] [Abstract][Full Text] [Related]
15. 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat.
Sporn MB; Squire RA; Brown CC; Smith JM; Wenk ML; Springer S
Science; 1977 Feb; 195(4277):487-9. PubMed ID: 835006
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
Clifford JL; Sabichi AL; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):391-5. PubMed ID: 11319181
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of 2-hydroxyethyl retinamide on urinary bladder carcinogenesis and tumor transplantation in Fischer 344 rats.
Quander RV; Leary SL; Strandberg JD; Yarbrough BA; Squire RA
Cancer Res; 1985 Nov; 45(11 Pt 1):5235-9. PubMed ID: 4053003
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, tissue distribution, and placental permeability of all-trans- and 13-cis-N-ethyl retinamides in pregnant hamsters.
Howard WB; Willhite CC; Omaye ST; Sharma RP
Fundam Appl Toxicol; 1989 Apr; 12(3):621-7. PubMed ID: 2731673
[TBL] [Abstract][Full Text] [Related]
19. Anticarcinogenic effects of retinoids in animals.
Moon RC; Mehta RG
Adv Exp Med Biol; 1986; 206():399-411. PubMed ID: 3591531
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of dietary or topical exposure to three retinoids in the promotion of skin tumor induction in mice.
McCormick DL; Bagg BJ; Hultin TA
Cancer Res; 1987 Nov; 47(22):5989-93. PubMed ID: 2959358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
